# Finance-Projects-Excel
Glenmark Pharmaceuticals – Market Risk & Financial Analysis (Excel Model)

Overview

This project analyzes the market risk exposure, capital structure, and overall financial health of Glenmark Pharmaceuticals using an Excel-based financial model. The objective was to evaluate systematic risk, return volatility, and leverage stability through structured quantitative analysis.

Key Areas Covered
	•	Estimated Beta using covariance–variance approach
	•	Calculated Cost of Equity using CAPM
	•	Analyzed log returns and stock volatility
	•	Assessed capital structure using debt-to-equity and interest coverage ratios
	•	Developed a financial health scorecard covering profitability, risk, growth, and stability metrics

## Dataset Used
- <a href= "https://github.com/iamag0512/Finance-Projects-Excel/blob/main/Glenmark%20Pharmaceuticals.xlsx"> Dataset view</a>

Methodology

Historical stock price data was used to compute returns and measure systematic risk relative to the market. Financial statement data was analyzed to evaluate leverage, debt-servicing capacity, and overall financial performance. All models were implemented in Microsoft Excel with structured calculations and summary outputs.

## Dashboard
- <a href= "https://github.com/iamag0512/Finance-Projects-Excel/blob/main/PHOTO-2026-02-13-23-02-29.jpg"> Dashboard View</a>

![PHOTO-2026-02-13-23-02-29](https://github.com/user-attachments/assets/c33faaec-a42e-4d34-b21a-7c742d700db9)


Key Insights

The analysis indicated moderate market sensitivity based on Beta estimation, with return volatility reflecting exposure to broader market movements. Capital structure evaluation highlighted the importance of leverage monitoring and debt sustainability under varying market conditions.

Tools Used

Microsoft Excel
CAPM Implementation
Variance–Covariance Analysis
Financial Statement Analysis
Risk and Return Modeling
